Cross-Site Scripting Vulnerability in IBM Maximo Application Suite
CVE-2024-35145

6.1MEDIUM

Key Information:

Vendor

IBM
Status
Maximo Application Suite
Vendor
CVE Published:
25 January 2025

What is CVE-2024-35145?

The IBM Maximo Application Suite Monitor Component is susceptible to a Cross-Site Scripting (XSS) vulnerability. This issue permits unauthenticated attackers to inject arbitrary JavaScript code into the web interface. As a result, the malicious script could manipulate the functioning of the application, which may lead to the unauthorized disclosure of sensitive user credentials within active sessions, compromising user security and application integrity.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Maximo Application Suite 9.0.0

References

https://www.ibm.com/support/pages/node/7174956

CVSS V3.1

Score:
6.1
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
Required
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.